← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...
HomeStocksPTHSRevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

Pelthos Therapeutics Inc. (PTHS) Revenue History

Annual and quarterly revenue from 2022 to 2024

TTM Revenue
$7.4M
0
YoY Growth
-
Latest Quarter
$7.4M
Q3 2025
QoQ Growth
-

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$0 (0)
Highest Quarter$7.4M (Q3 2025)
Revenue per Share$12.60

Loading revenue history...

Revenue Growth Metrics

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Revenue per Share$12.60
Peak Annual Revenue$0 (0)

Download Historical Data

3 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PTHS Revenue Analysis (2022–2024)

As of March 1, 2026, Pelthos Therapeutics Inc. (PTHS) generated trailing twelve-month (TTM) revenue of $7.4 million. The most recent quarter (Q3 2025) recorded $7.4 million in revenue.

Looking at the longer-term picture, PTHS's historical revenue data shows various trends over time.

When compared to Healthcare sector peers including UTHR (+10.6% YoY), ZLAB (+15.3% YoY), and AMRN (-6.2% YoY). Compare PTHS vs UTHR →

Peer Comparison

Compare PTHS's revenue metrics with industry peers

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
PTHSCurrent$7M---
UTHR$3.2B+10.6%+16.5%46.9%
ZLAB$460M+15.3%+56.5%-49.9%
AMRN$229M-6.2%-11.9%-40.2%
ALKS$1.5B-5.2%+7.3%17.2%
ADMA$426M+27.6%+70.8%32.6%
Best in groupLowest in group

Historical Revenue Data

Showing 3 of 3 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2024$0-$0-$-7,571,449-
2023$0-$0-$-6,862,284-
2022$0-$0-$-2,318,159-

See PTHS's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is PTHS Undervalued?

See our Bear / Base / Bull DCF models and intrinsic value estimates.

View Valuation

Compare PTHS vs AGIO

See how PTHS stacks up against sector leader Agios Pharmaceuticals, Inc..

Start Comparison

Frequently Asked Questions

Is PTHS's revenue growth accelerating or slowing?

PTHS TTM revenue: $7M. YoY growth: N/A. 5-year CAGR: N/A.

What is PTHS's long-term revenue growth rate?

Pelthos Therapeutics Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is PTHS's revenue distributed by segment?

PTHS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2024 are available for download. Segment mix reveals concentration and diversification trends.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.

Revenue Over Time